Gudpres-AM 25 Tablet PR is a combination antihypertensive medication containing Amlodipine 5 mg and Metoprolol Succinate 25 mg. Amlodipine is a calcium channel blocker that acts by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced peripheral resistance, thereby lowering blood pressure. Metoprolol Succinate is a cardioselective beta-1 adrenergic receptor blocker that decreases heart rate, myocardial contractility, and cardiac output, contributing to blood pressure reduction and improved cardiac function. This combination is indicated for the management of hypertension and angina pectoris, providing synergistic effects through dual mechanisms to achieve optimal cardiovascular control. Gudpres-AM 25 Tablet PR is administered orally, typically once daily, with dosage adjustments based on therapeutic response and tolerability. The extended-release formulation of Metoprolol Succinate ensures sustained plasma concentrations, promoting consistent blood pressure control over 24 hours. Caution is advised in patients with bradycardia, heart block, severe peripheral arterial disease, or hepatic impairment. Common adverse effects may include dizziness, fatigue, hypotension, and peripheral edema. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. Gudpres-AM 25 Tablet PR should be used under medical supervision to optimize treatment outcomes and minimize risks.